Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease.
Baird, Kristin; Comis, Leora E; Joe, Galen O; Steinberg, Seth M; Hakim, Fran T; Rose, Jeremy J; Mitchell, Sandra A; Pavletic, Steven Z; Figg, William D; Yao, Lawrence; Flanders, Kathleen C; Takebe, Naoko; Sarantopoulos, Stefanie; Booher, Susan; Cowen, Edward W.
Biol Blood Marrow Transplant
; 21(6): 1083-90, 2015 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-25771402
Successful use of miniphotopheresis for the treatment of graft-versus-host disease.
Concise review: the bone marrow niche as a target of graft versus host disease.
Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy.
GVHD prevents NK-cell-dependent leukemia and virus-specific innate immunity.
The Sequence of Cyclophosphamide and Myeloablative Total Body Irradiation in Hematopoietic Cell Transplantation for Patients with Acute Leukemia.
How I treat bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
Impact of very early CD4(+) /CD8(+) T cell counts on the occurrence of acute graft-versus-host disease and NK cell counts on outcome after pediatric allogeneic hematopoietic stem cell transplantation.
A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial.
Graft-versus-host disease in stem cell transplantation.
Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.